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ABSTRACT 
Background: Remaining physically active during and after cancer treatment is 
known to improve associated adverse effects, improve overall survival and reduce 
the probability of relapse. This systematic review addresses the question: is an 
exercise-training programme beneficial in people with cancer undergoing adjuvant 
cancer treatment following surgery. 
Methods: A systematic database search of Embase, Ovid, Medline without 
Revisions, SPORTDiscus, Web of Science, Cochrane Library and clinical trials.gov 
for any randomised controlled trials (RCT) or non-RCT addressing the effect of an 
exercise training programme in those having adjuvant cancer treatment following 
surgery was conducted. 
Results: The database search yielded 6,489 candidate abstracts of which 94 
references included the required terms. A total of 17 articles were included in this 
review. Exercise training is safe and feasible in the adjuvant setting and furthermore 
may improve measures of physical fitness and health related quality of life 
(HRQoL). 
Conclusion: This is the first systematic review on exercise training interventions in 
people with cancer undergoing adjuvant cancer treatment following surgery. Due to 
the lack of adequately powered RCTs in this area, it remains unclear whether 
exercise training in this context improves clinical outcomes other physical fitness 
and HRQoL.  It remains unclear what is the optimal timing of initiation of an 
exercise programme and what are the best combinations of elements within an 
exercise training programme to optimise training efficacy.  Furthermore, it is unclear 
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if initiating such exercise programmes at cancer diagnosis may have a long-lasting 
effect on physically activity throughout the subsequent life course. 
Keywords: Cancer, Surgery, Adjuvant cancer treatment, Exercise Intervention 
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BACKGROUND 
People with cancer are often faced with the “dual-hit” of surgery and an additional 
cancer treatment, such as adjuvant chemo- or chemoradio-therapy. Chemo- or 
chemoradio-therapy in upper and lower gastrointestinal cancer in the neoadjuvant 
setting has been associated with a decrease in physical fitness (1, 2).  Furthermore, 
this decrease in physical fitness, as a result of such cancer treatments, was found to 
be related to mortality and morbidity, respectively (1, 2). The reduction in physical 
fitness appears to be related to the type of treatment they undergo, higher in those 
receiving surgery and radiotherapy in combination with chemotherapy compared to 
those who receive radiotherapy alone or surgery(3). Major surgery is associated with 
significant risk of morbidity and mortality, as recently highlighted in the European 
Surgical Outcome Study(4). Morbidity has a great impact on the recovery process 
post-operatively and is associated with long-term health implications including 
reduced survival(5, 6). Prolonged post-operative morbidity has been associated with 
an increased risk of death for up to 3 years after surgery(6), however mechanisms for 
this phenomenon currently remains unanswered. Moreover, the decrease in physical 
fitness as a result of cancer treatment may have a lasting effect. In a series of cancer 
studies, cardiorespiratory fitness was ~30% below that of age-matched sedentary 
healthy women up to 3 years following completion of adjuvant cancer treatment [11, 
12, 16]. 
Higher aerobic capacity has been associated with longer cancer-specific survival and 
lower cancer related mortality (7). Remaining physically active during and after 
cancer treatment is known to improve associated adverse effects, as well as improve 
overall survival and reduce the probability of recurrence (8). However, physical 
activity levels tend to decrease at diagnosis in people with cancer (9). Furthermore, a 
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significant decrease in physical activity has been associated to a higher level of 
fatigue during breast cancer treatment (10). Increasing physical activity levels by 
50% following colorectal cancer diagnosis has been shown to decrease both the risk 
of colorectal cancer-specific and all-cause mortality (11). Additionally, a higher level 
of physical fitness has been related to longer cancer-specific survival and lower 
cancer-related mortality (7). It has been suggested that women with breast cancer 
who exercise at moderate intensity, 30 minutes or more per day on 5 days or more 
per week, have a lower risk of death (12). 
The area of exercise-oncology has attracted great interest over recent years with a 
number of high-quality clinical trials and systematic reviews conducted in this area. 
In 2011, Granger and colleagues reported that it was safe to exercise people with 
non-small cell lung cancer (NSCLC) during and following cancer treatment (13). In 
2014, Crandall and colleagues (14) undertook a systematic review specifically 
investigating exercise interventions in people with NSCLC but in those requiring 
surgery which showed there was a lack of trials which influenced surgical outcome 
(14). We aimed to explore all available literature focussing on exercise interventions 
in people with cancer undergoing adjuvant cancer treatment following surgery.  
OBJECTIVES 
The objective of this review is to evaluate methods, safety and feasibility, outcomes 
(including physical fitness, health related quality of life (HRQoL), fatigue, post-
operative clinical outcomes), in studies that have tested exercise interventions in 
people with cancer undergoing both surgery and adjuvant cancer treatment 
(excluding exercise interventions initiated following adjuvant cancer treatment).  
RESEARCH QUESTIONS 
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1. Is exercise training in people with cancer undergoing adjuvant cancer 
treatment following surgery safe and feasible? 
2. Does exercise training in people with cancer improve some measure of 
physical fitness (including physical capacity and physical activity), HRQoL 
and other clinically relevant outcomes such as fatigue and post-operative 
outcome and what aspects have been reported to be effective? 
3. What is the optimal timing of initiation of an exercise intervention, optimal 
structure and composition of an exercise training programme, optimal 
approaches to promote adherence and behaviour towards exercise, and 
whether such an intervention has a long-term effect on physical activity 
levels? 
METHODS 
Inclusion Criteria 
Type of studies 
We considered randomised and non-randomised controlled trials (RCT) investigating 
exercise training in people with cancer undergoing adjuvant cancer treatment 
following surgery.  
Type of participants 
We included studies that recruited human adults (>18 years) with cancer undergoing 
an exercise intervention,cancer surgery and adjuvant cancer treatment.  
Type of exercise intervention 
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The criterion for study inclusion were evaluation and reporting of the effect of an 
exercise intervention during adjuvant cancer treatment (defined as cancer surgery 
followed by adjuvant chemo- or chemoradio-therapy) on safety and feasibility or, a 
measure of physical fitness (including physical capacity and physical activity) or 
HRQoL. Other clinical outcomes such as fatigue, post-operative morbidity and 
mortality, post-cancer treatment morbidity and mortality were also included. The 
intervention could take place in any setting and be delivered to a group or an 
individual participant. This also included interventions done alone or in combination: 
1) aerobic training (defined as exercise that involves large muscle groups performing 
continuous or intermittent activity over an extended period of time) (15); 2) 
prescribed resistance training (defined as exercise that involves performing sets of 
repeated movements against a resistance during which neuromuscular fatigue occurs 
within 6-12 repetitions (16)); 3) pelvic floor exercise. 
 
Type of outcome measured 
The outcomes of interest assessing the effects of an exercise intervention in the 
adjuvant setting after cancer surgery were: 
1. Safety and feasibility 
2. Measure of physical fitness (including physical function, physical capacity 
and physical activity) 
3. HRQoL 
4. Clinical outcomes (post-operative morbidity and mortality, post-cancer 
treatment morbidity and mortality)  
5. Other clinically relevant outcomes such as fatigue, and whether such an 
intervention has a long-term effect on physical activity levels. 
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The outcomes of interest assessing the elements and composition of an exercise 
intervention in the adjuvant setting after cancer surgery were: 
6. Optimal timing of initiation of exercise intervention 
7. Optimal structure and composition of an exercise training programme 
8. Optimal approaches to promote adherence and behaviour towards exercise 
 
Search methods for identification of studies 
Electronic searches 
We performed a comprehensive, systematic search on 23 May 2013 and three further 
updated searches on 1 October 2014, 1 December 2014 and 1 April 2015. Relevant 
keywords were categorised under five distinct headings: (i) cancer, (ii) cancer 
treatment, (iii) exercise, (iv) surgery and (v) outcome. (See appendix 1 for 
illustration of all search terms and strategy). First, each category was searched 
separately in the database. A combined search of all the categories was completed 
and duplicate results were removed. We used the following databases to obtain 
relevant studies for this review; 
• Embase 
• Ovid Medline without Revisions 
• SPORTDiscus 
• Web of Science 
• Cochrane Library database 
• clinical trials.gov 
Searching other resources 
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• We checked the reference lists of all articles obtained for additional studies. 
• A manual title search of references from the previous review articles on exercise 
and cancer was also conducted.  
• We attempted to communicate with the study authors to secure information not 
presented in the studies. 
Data collection and analysis 
We conducted a systematic search for all clinical trials that involved people with 
cancer undergoing any form of adjuvant cancer treatment following surgical 
intervention who exercise-trained in this setting. Data was extracted by one 
investigator in accordance with predefined criteria. We retrieved all studies in which 
the abstract made reference to an exercise intervention in people with cancer 
undergoing both surgery and adjuvant cancer treatment. Abstracts were screened and 
reviewed against predefined inclusion and exclusion criteria by two independent 
assessors (LL and MW), and scored using the Downs and Black quality assessment 
tool (17). Abstracts that met the inclusion criteria were independently assessed by 
two reviewers (LL and MW) for descriptive characteristics such as; 
• Participant characteristics 
• Study design 
• Type of cancer and cancer treatment (surgery and adjuvant cancer treatment) 
• Type and length of exercise intervention  
• An outcome measure 
In addition, descriptive data were extracted about the each exercise interventions 
such as; 
• Frequency 
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• Intensity 
• Time 
• Type 
• Supervision 
• Location 
• Adherence 
Assessment of methodological quality 
Two reviewers (LL and MW) independently scored the methodological quality of 
each study according to the Downs and Black quality appraisal checklist (17). This 
checklist consists of 27 questions to evaluate internal validity and external validity of 
both randomised and non-randomised studies. Each question was scored out of 1, 
except question 5 that was scored out of 2 and question 27 that was scored out of 5, 
giving a total score of 33. High scores reflect high-quality studies. All discrepancies 
were resolved by discussion between all authors (see appendix 2) 
Meta-analysis 
A decision to conduct a meta-analysis was based on the following pre-defined 
criteria;  
• To increase power; detecting a real effect as statistically significant if it exists. 
However, many individual studies are too small to detect small effects, but 
when several are combined there is a higher chance of detecting an effect. 
• To improve precision; the estimation of an intervention effect can be 
improved when it is based on more information. 
• To answer questions not posed by the individual studies.  
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• To settle controversies arising from apparently conflicting studies or to 
generate new hypotheses.  
A decision not to conduct a meta-analysis was based on the following pre-defined 
criteria;  
• If studies were clinically diverse 
• If there were a mix of comparisons of different treatments with different 
comparators.  
• Decisions concerning what should and should not be combined are inevitably 
subjective, and are not amenable to statistical solutions but require discussion 
and clinical judgement. In some cases consensus may be hard to reach. 
• If bias is present in each (or some) of the individual studies. 
RESULTS 
Description of studies 
The database search strategy that included exercise interventions in people with 
cancer undergoing both cancer surgery and adjuvant treatment is shown in appendix 
3. This search yielded 6489 candidate abstracts. After review of the candidate 
abstracts by two independent reviewers (LL and MW), 94 references included the 
required terms, of which 72 references were excluded as they did not meet all 
inclusion criteria. 22 references were extracted for full text review, of which 7 
references were included. A manual search through all the references from full text 
papers identified for inclusion resulted in an additional 17 full text papers extracted 
for review of which, 5 references were eligible for inclusion. 5 additional references 
were identified for inclusion following the most recent updated searches.  After full 
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text screening and application of all inclusion criteria, 17 articles were eligible for 
inclusion in this review. Meta-analyses were not performed due to the diverse 
clinical and statistical heterogeneity of the included studies.  
Description of study aims and outcome measures 
Summary of study aims and outcome measures is illustrated in table 1. 
Description of study characteristics and exercise intervention outcomes 
Summary of study characteristics and exercise intervention outcomes is illustrated in 
table 2. 
Physical Fitness Outcomes 
A measure of physical fitness was used as a primary outcome in only 4 studies in 
people with breast cancer (3, 18-20). A measure of physical fitness was used as a 
secondary outcome in the majority of the studies: physical functioning (21) (22, 23); 
aerobic capacity (24)); muscular strength (3, 25-28) (19, 24); passive range of 
movement shoulder rotation (29); cardiopulmonary fitness endpoints (peak 
workload, ventilatory threshold, oxygen pulse (30)), flexibility (19), lean body mass 
and percent body fat/body weight (26, 27). 
Only one study reported improvements in oxygen uptake at peak exercise (V& o2peak), 
as a primary endpoint, albeit not statistically significant (30). Moderate intensity 
aerobic training during adjuvant radiotherapy was suggested to preserve or maintain 
exercise tolerance, although not statistically significant, as measured by 6-minute 
walk distance test (6MWD). Two studies reported a significant increase in V& o2peak 
as their secondary outcome (19, 25). Courneya and colleagues (26) reported a 
significant improvement in V& o2peak in the aerobic exercise training group but not in 
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the resistance exercise training group or the usual care group. One home-based 
exercise programme illustrated a significant improvement in physical fitness as 
measured by 12-MWD(23). The pectoral stretching programme reported no 
differences at the 7 month follow-up (29). Other studies illustrated improvements in 
a measure of physical fitness, although not statistically significant, following the 
exercise programme (20, 24) (29).  
One study in people with breast cancer reported a slight worsening in Karnofsky 
performance status in both groups following chemotherapy (not significantly 
significant) (3). Furthermore, there was a significant decrease in physical functioning 
in women with high fatigue levels during breast cancer therapy (10). Physical 
functioning was found to improve following initiation of a home-based rehabilitation 
exercise programme 66-hours post-hospital discharge by 6 weeks, assessed using 
Medical Outcomes Short Form-36 (SF-36) was illustrated (31). Following the 
exercise intervention, three studies reported increased physical activity levels, 
although insignificant (21, 22, 25).  
HRQoL Outcome 
HRQoL, as the primary outcome, was measured by three included studies (20, 26, 
27). HRQoL was used in almost all studies as a secondary outcome measure. 
Exercise training significantly improved different domains of HRQoL following 
circuit classes over a 12-week period (22), a 16-week period (19) and 
aerobic/resistance exercise program over a 17-week period (27). Following the 
START trial significant improvements in some HRQoL domains were reported, but 
no significant improvement in cancer-specific HRQoL (fatigue, depression or 
anxiety) (27). Following the multi-modal high intensity exercise programme, there 
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was a mixture of HRQoL responses reported (25). There was a decrease in HRQol 
between pre- and post-surgery and an increase following the 6-week exercise 
programme with the best results obtained at week-3 in the study in people with  
NSCLC. However, 5 out of the 7 participants in this trial initiated chemotherapy at 
week 5 which may account for the slight decrease from week 3 to week 6 (31). There 
was no statistically significant differences in HRQoL reported following the pectoral 
training programme, self-directed versus supervised walking intervention or 
progressive resistance training programme (20, 29, 32). 
Fatigue symptoms and other clinical outcomes 
Fatigue was used as a primary outcome in five included studies (10, 21, 24, 31) (32). 
Adamsen and colleagues (25) reported that 65% of study population had a fatigue 
level greater than that of general population (mean >20) at baseline and that 29% 
reported severe fatigue (mean >60). Furthermore, they also report that 18% of the 
participants had a sedentary lifestyle at baseline and suggested that reported fatigue 
might be primarily due to cancer or the chemotherapy. Schmidt and colleagues (32) 
illustrated a change in fatigue levels from baseline to post intervention however the 
results did not reach statistical significance. Husebo and colleagues (21) reported a 
statistical significant finding in fatigue levels 6 months following completing the 
exercise programme, initiated during cancer treatment. Moderate intensity home-
based walking intervention was found to be effective in managing fatigue levels 
during both radiotherapy and chemotherapy (10). Moros and Campbell and 
colleagues (3, 22) reported no statistically significant changes following an aerobic 
exercise program. Hoffman and colleagues (31) monitored cancer-related fatigue 
(CRF) and symptom severity from pre-surgery to week-6 of their exercise 
programme, finding that on average participants experienced 7 symptoms pre-
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surgery, 10 symptoms post-surgery and 6 symptoms at week 6. In this study CRF 
increased from 3.5 to 4.8 pre- to post-surgery and decrease to 2.8 at week 6, with 
other symptom severity and interference results showing a similar trend (5 out of 7 
participants commenced chemotherapy at week 5). Naraphong and colleagues 
demonstrated an improvement in CRF from baseline to the 10-week follow up, albeit 
not statistically significant (23). 
Naraphong and colleagues(23) also assessed sleep disturbance (General Sleep 
Disturbance) and mood disturbance (Profile of Mood States-Brief Form). Although 
participants in the exercise group did demonstrate improvements in mood and 
symptom distress, results did not reach statistical significance.  
Schmidt and colleagues (32) assessed depression (20-item Center for 
Epidemiological Studies Depression scale) and cognitive function (concentration, 
cognitive flexibility). There was no statistical significance in either measure with no 
difference illustrated in depression in either control or exercise group however 
cognitive performance did improve in the exercise group only. 
Behaviour 
Only Courneya and colleagues (28) investigated predictors of follow-up exercise 
behaviour 6 months following a RCT exercise trial as a primary outcome, finding a 
number of significant predictors such as; demographics, medical, fitness, psycho-
social and motivational variables. Moreover, 58% of breast cancer survivors reported 
meeting at least one exercise guideline and 21% of those reported meeting both 
following the START trial. At baseline, only 23% were meeting either exercise 
guideline and only 5% of those were meeting both. The strongest predictor of those 
exercising at 6-month follow-up in their trial was pre-trial exercise levels. 
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Additionally, other variables that predict the likelihood of meeting exercise 
guidelines at follow up included younger age, breast conserving surgery, strength 
improvements, lower post-intervention fatigue, a more positive attitude and lower 
post intervention BMI.  
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DISCUSSION 
 
This is the first systematic review aimed to synthesise all available literature of exercise 
training intervention in people with cancer undergoing adjuvant cancer treatment following 
surgical resection. Although the area of exercise-oncology is still relatively new with only 
seventeen studies being considered eligible for review, the principal finding is that exercise 
training is safe and feasible in the adjuvant setting. The review included studies with various 
forms of exercise interventions and those that mainly investigated HRQoL as a primary 
outcome. The evidence does suggest that exercise intervention during adjuvant cancer 
treatment may improve measures of physical fitness, HRQoL and fatigue, albeit that not all 
such findings were statistically significant. The question of which is the most effective 
exercise training programme aimed at improving physical fitness cannot be answered, with 
only 1 pilot study (in people with breast cancer) reporting a statistically significant increase in 
physical fitness as a primary outcome measure (19). It remains unclear what the optimal 
timing of initiation of an exercise programme is and what are the best combinations of 
elements within an exercise training programme to optimise training efficacy.  Furthermore, 
it also remains unclear whether exercise training in this context improves clinical outcomes 
and whether such exercise interventions have a long-lasting effect on physically activity 
throughout the subsequent life course of the patient.  
The quality of the included studies in this review were variable. Of the seventeen full text 
articles, thirteen were reported as an RCT (3, 9, 10, 18, 20-22, 24, 26-29, 32) however three 
studies were by Courneya and colleagues (26-28) (results from one exercise training trial, the 
START trial).  Of these only 4 studies include >200 patients (9, 26-28) and 3 studies 100-200 
patients (10, 20, 32); the remaining 9 studies included 7-67 patients (3, 18, 19, 21-24, 30, 31, 
33). All except three studies (19, 30, 31) included a control group. The majority of included 
studies involved those with breast cancer which suggests more research is required in other 
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cancer groups. Furthermore, it is difficult to compare such included studies as they were 
heterogeneous for the type of cancer (breast, NSCLC and one study including 21 different 
cancer types), cancer treatments and the initiation of the exercise training programme. The 
exercise training varied in the type of programme (mainly aerobic and resistance exercise 
training), supervision and setting (supervised in-hospital and unsupervised at home), 
frequency (2-26 weeks), intensity (mainly moderate aerobic with high intensity in two studies 
(9)), time (15- 60 minutes) and type (mainly cycle ergometer) of exercise. Adherence ranged 
between 15 – 90% (home-based and in-hospital exercise training). In comparison, reported 
adherence rates for surgical prehabilitation studies also range widely, e.g. 16% in colorectal 
cancer (34) and 81% in people with lung cancer (35) for home-based training programmes 
and 100% for an in-hospital supervised programme in abdominal aortic aneurysm repair 
patients (36).  
Overall, exercise training during adjuvant cancer treatment has been found to be safe and 
feasible in people with breast cancer (19, 22) and NSCLC (30). Only Jones (30) and 
Campbell (22) and colleagues explored fatigue levels in these feasibility studies. Jones and 
colleagues illustrated a significant improvement following the exercise intervention in people 
with NSCLC. Although Campbell and colleagues illustrated an improvement in fatigue levels 
in the intervention group, albeit this did not reach statistical significance. People with cancer 
encounter worsening symptoms from cancer, cancer treatment and surgery, yet the included 
studies highlight the efficacy of implementing exercise programmes during this time (30). 
The feasibility of initiating an exercise programme, even in people with NSCLC, is 
encouraging as people included in this review were older, had a poor exercise tolerance, a 
diverse range of co-morbidities and recently underwent surgical interventions (30, 31). 
Furthermore, this review included a group of participants with NSCLC, of whom, almost one 
third received platinum-based chemotherapy whilst undertaking exercise training (30). One 
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study in people with NSCLC tolerated exercise training initiated at 66-hours post hospital 
discharge (31). Only one study in this review reported a participant becoming unwell during 
the exercise programme but quickly recovered (26). 
It has been suggested that women with breast cancer who exercise at moderate intensity, 30 
minutes or more per day on 5 days or more per week, have a lower risk of death (12). 
Furthermore, exercise training might ameliorate toxicity, completion rate and cancer 
treatment efficacy (37). However, studies reviewed here provide little insight into detailing 
the most effective components that might influence such outcomes. Considering the role of 
strength/muscular training, a recent meta-analysis (38) concluded that resistance training was 
associated with clinically important improvements in muscular function and body 
composition in patients undergoing cancer treatment and long term follow-up. Most of the 
studies included in this review did indeed incorporate a form of resistance exercise although 
only Battaglini and colleagues (24) reported significant findings. Courneya and colleagues 
(26, 27) reported that chemotherapy moderated the effects of exercise training on muscular 
strength with patients receiving non-taxane based chemotherapy increasing muscular 
strength. Moreover, this resistance exercise training programme improved cancer treatment 
completion rate. Peripheral muscle strength is known to be related to physical activity in 
patients with chronic obstructive pulmonary disease (COPD) (39), though this has not been 
studied in people with cancer .  
Preparing for the “dual-hit” treatment including surgery and adjuvant cancer treatment can 
cause unanticipated fear, anxiety and psychological stresses. HRQoL is much studied in 
oncology (40). The studies included in this review on the whole support the conclusion of 
Granger and colleagues (13) such that exercise training is associated with positive benefits on 
some domains of HRQoL. Exercise training significantly improved different domains of 
HRQoL following circuit classes (19, 22) and aerobic/resistance exercise programmes (27).  
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Burke and colleagues (41) explored experiences of participants in an in-hospital exercise 
programme using semi-structured interviews, finding that it promoted positive changes, as 
patients viewed their lives in a “fuller, richer and more meaningful way”. Campbell and 
colleagues (22) found over their 12-week exercise intervention period a change in FACT G 
score of ~15 units, representing the difference between requiring bed rest half the waking day 
to being fully ambulatory with symptoms (42).  
Fatigue is one of the commonest symptoms of cancer and cancer treatment, manifested in the 
clinic as weakness and exercise intolerance, which can effect quality of life and physical 
activity (41). Insight into strategies that help patients overcome barriers to exercise may help 
patients adopt and maintain physical activity (43). It has been suggested that people with 
cancer  interested in participating in physical activity preferred to receive information from a 
cancer centre or face to face as opposed to leaflets (43). Courneya and colleagues (28) 
stressed the importance of fully considering demographic, medical, behavioural, fitness, 
psychosocial and motivational factors when designing behavioural support interventions to 
promote exercise during the important transition from breast cancer patient to survivor. 
Encouragingly, Campbell (22) and Adamsen (9) and colleagues reported increased physical 
activity levels post-exercise training intervention. The first RCT (The CHALLENGE Trial) 
investigating physical activity levels and survival is currently being conducted among colon 
cancer survivors following completion of adjuvant chemotherapy (44). 
The main strength of this review is that it provides an up-to-date comprehensive review of all 
studies using an exercise programme in people with cancer undergoingadjuvant cancer 
treatment following surgery. The review was conducted in a rigorous manner using selected 
search terms over several databases. Searches were updated over several time points. 
Furthermore, two independent assessors screened candidate articles using predefined search 
terms which minimised bias.  The quality of each study was evaluated by using a checklist 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
designed to assess randomized and non-randomized trials. The main limitation of this review 
is the limited number of reports available (of which 3 referred to a single exercise 
programme, the START trial (26-28)). Not all studies reported initial baseline fitness levels, 
and some studies excluded people with cancer who were already vigorously exercising 3 
times a week for 20 minutes or more. Furthermore, not all studies specified the timing of 
assessments, duration of exercise programmes and the nature of the cancer treatment 
received. Some studies offered incentives such as massages [35] to continue the exercise 
programme which limits future application of such exercise interventions. Due to the nature 
of the literature, only three of the seventeen included studies included mixed genders, all 
other studies included females with breast cancer which limit generalisability.  Finally, due to 
the clinical and statistical heterogeneity of the included studies, a meta-analysis was not 
performed 
 
CONCLUSION 
This is the first systematic review including all people with cancer undergoing adjuvant 
cancer treatment following surgery. Consistent with findings presented in a recent review 
(37), we agree that the majority of  work conducted in the adjuvant setting mainly includes 
people with breast cancer. This review included 1370 people with breast cancer and 296 
people with other cancer types. However, in comparison our review has focussed on all 
people with cancer undergoing adjuvant cancer treatments following surgery. Of the 17 
included studies, 6 have been conducted in the past 5 years. Because of the lack of adequately 
powered RCTs in this area, it remains unclear what is the optimal time to initiate an exercise 
programme and the kind of programme effective in improving clinically important outcome 
measures. Future studies should focus on the mechanisms of cancer treatment and a 
comparison of different exercise programmes. It remains unclear whether exercise training in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
this context improves clinically important outcomes other than measures of physical fitness, 
HRQoL and fatigue. The question of what is the optimal timing of initiation of an exercise 
programme and what the best combination of elements within an exercise-training 
programme to optimise training efficacy remain currently unanswered.  It is also unclear if 
initiating such exercise programmes at cancer diagnosis may have a long-lasting effect on 
long term physical activity and survivorship. Finally, it is encouraging that people with 
cancer  undergoing the "dual-hit" can tolerate exercise training and perhaps global exercise 
guidelines for people with cancer   can be further specified and recommended. 
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Table 1. Summary of study aims and outcome measures 
Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
Segal et al, 2001 
(Canada) 
Breast, 
Adjuvant chemo/ 
other adjuvant 
cancer treatment 
Walking Evaluate the effect of exercise 
on physical functioning and 
other dimensions of HRQoL. 
Self-directed and supervised 
exercise were compared with 
usual care 
1. Physical functioning (SF-36) 
2. Changes in other scales of SF-36, FACT-General and FACT-
Breast, aerobic capacity and body weight 
Kolden et al, 
2002              
(USA) 
Breast, 
Adjuvant 
radiotherapy 
Aerobic/ 
Resistance/ 
stretching 
Feasibility, safety and 
tolerability,  benefits of a 
comprehensive group exercise 
intervention 
1. Recruitment and retention and safety and tolerability report 
2. Secondary outcome measures are listed below; 
• Aerobic capacity; a single-stage submaximal treadmill walking 
test 
• Flexibility; Sit-And-Reach Test 
• Strength; estimated 1-RM tests on bench press and leg press 
• HRQoL- Mood/distress; 
Beck Depression Inventory (BDI), State-Trait Anxiety 
Inventory, Positive and Negative Affect Schedule (PANAS), 
Hamilton Rating Scale for Depression (HRSD) 
• HRQoL- Well-being; 
Functional Assessment of Cancer Treatment (FACT), the Life 
Functioning Scales (LFS) 
• HRQoL- Functioning; 
Cancer Rehabilitation Evaluation System (CARES), Global 
Assessment Scale (GAS) 
Campbell et al, 
2005 
Breast, 
Adjuvant 
radiotherapy & 
Circuit aerobics Evaluate physical functioning, 
fatigue and QoL outcomes 
1. Cancer-specific QoL scales; FACT-General and FACT-Breast 
2. Secondary outcome measures are listed below; 
• Global QoL tool; Satisfaction with Life Scale (SWLS) 
• Fatigue; Revised Piper Fatigue Scale (PFS) 
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Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
(UK) chemo • Physical; Scottish physical activity questionnaire (SPAQ) and 
12MWT 
Mock et al, 2005  
(USA) 
Breast 
Adjuvant 
radiotherapy 
 
Walking 
 
To determine the effects of a 
home-based walking exercise 
programme on levels of fatigue 
 
1. Fatigue; total score of Piper Fatigue Scale (PFS) 
2.  Physical functioning and activity levels: 12-MWD, Medical 
Outcomes SF-36 and physical activity questionnaire (PAQ) 
Battaglini et al, 
2006               
(USA) 
Breast 
Adjuvant Chemo, 
radiation or both 
CV/ 
Resistance/ 
flexibility 
 
To identify the possible benefits 
that an individualised exercise 
programme composed 
primarily of resistance training 
would have on muscular 
strength and fatigue levels 
1. Fatigue; total score of Piper Fatigue Scale (PFS) 
2.  Fitness assessment; VO2peak/max test using the Bruce 
treadmill protocol and maximum capacity for muscular 
strength 
Courneya et al, 
2007         
(Canada) 
Breast, 
Adjuvant chemo 
Aerobic/ 
Resistance 
Evaluated the effects of aerobic 
and resistance exercise on 
physical functioning, body 
composition, psychosocial 
functioning and QoL 
1. Functional assessment of cancer therapy-anaemia scale 
(FACT-An scale) and Psychosocial functioning; Rosenberg 
Self-esteem scale 
2. Secondary outcome measures are listed below; 
• Aerobic fitness; maximal incremental exercise treadmill 
protocol 
• Muscular strength; 8-repetition maximum on horizontal 
bench press and leg extension. 
Lee et al, 2007 
(Australia) 
Breast, 
Adjuvant 
radiotherapy 
Pectoral muscle 
stretching 
programme 
To investigate whether a 
stretching programme reduced 
acute musculoskeletal 
impairments 
1. Passive range of movement for horizontal extension 
2. Secondary outcome measures are listed below; 
• Passive range of movement for forward flexion and external 
rotation 
• Active range of movement for abduction, 
• Strength of shoulder muscles 
• Arm swelling 
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Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
• QoL 
Courneya et al, 
2008,        
(Canada) 
Breast, 
Adjuvant chemo 
Aerobic/ 
Resistance 
Personal and clinical factors 
that may predict exercise 
training responses 
1. Qol; functional assessment of cancer therapy-anaemia (FACT-
An scale) 
2. Secondary outcome measures are listed below; 
• Aerobic fitness; maximal incremental exercise treadmill 
protocol 
• Muscular strength; 1-RM equation using 8-RM horizontal 
bench press 
• Lean body mass; DEXA scan 
• Percent body fat; Hologic QDR-4500 in Vancouver and the 
General Electric Lunar Expert in Ottawa and Edmonton 
Jones et al, 2008 
(Canada) 
Lung, 
Adjuvant chemo & 
some received no 
chemo 
Cycle 
 
Assess feasibility study 
examining the effects of a 
supervised aerobic exercise 
training on aerobic fitness 
1. Change in VO2peak; CPET 
2. Secondary outcome measures are listed below; 
• Secondary cardiopulmonary endpoints; peak workload, 
ventilatory threshold, O2 pulse and secondary QoL endpoints 
were overall fatigue and QoL subscale. endpoints; 
• QoL; Functional Assessment of Camcer Therapy-Lung (FACT-
L), Lung Cancer Subscale (LCS), 
• Fatigue; Fatigue Scale of the FACT measurement system 
Adamsen et al, 
2009      
(Denmark) 
21 different 
cancers, 
59 different chemo 
regimens 
Resistance, 
relaxation, body 
awareness and 
massage 
To assess the effect of a 
multimodal group exercise 
intervention, as an adjunct to 
conventional care on fatigue, 
physical capacity, general 
wellbeing, physical activity and 
QoL. 
1. Fatigue; European Organisation for Research and Treatment 
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) 
2. Secondary outcome measures are listed below; 
• QoL; 
Other scales on EORTC QLQ-C30 
General well-being was further assessed by Medical 
Outcomes Study Short Form (MOS SF-36) 
• Leisure time physical activity level; questionnaire 
• Muscular strength; 1-RM 
• Aerobic capacity; VO2max 
Courneya et al, 
2009          
Breast, Aerobic/ To identify key predictors of 
aerobic and resistance exercise 
1. Predictors of follow-up exercise behaviour 
2. Variables such as; 
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Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
(Canada) Adjuvant chemo Resistance during the follow-up phase of 
the START Trial. 
• Demographics and behavioural 
• Medical 
• Post-intervention 
• Change scores for physical fitness and body composition 
• Motivational variables 
Moros et al, 2010 
(Spain) 
Breast, 
Adjuvant chemo 
Aerobic / 
resistance 
To assess functional capacity, 
QoL and pyshco-social status of 
patients. Assess the influence of 
physical exercise programme 
throughout the course of 
chemotherapy. 
1. Functional capacity; Karnofsky performance status 
2. Secondary outcome measures are listed below; 
• Psychological wellbeing; General Health Questionnaire (GHQ) 
• QoL; The European Organisation for Research and Treatment 
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) 
Milecki et al, 
2013         
(Poland) 
Breast, 
Adjuvant 
radiotherapy 
Aerobic 
Endurance, 
Respiratory 
muscle training 
Examine whether moderate-
intensity endurance training 
would have a positive effect on 
aerobic capacity in comparison 
with those women who were 
not taking any physical activity 
during postoperative 
radiotherapy 
1. Functional capacity; 6MWD 
2. Breathlessness; Modified Borg scale (0-10)  
Hoffman et al, 
2014              
(USA) 
NSCLC, 
Chemo (initiated 
week 5 in 5/7 
patients) 
 
Walking and 
balancing 
program 
(Nintendo Wii 
Fit Plus) 
Describe the effects of a home-
based rehabilitation exercise 
intervention on CRF, other 
symptoms, functional status 
and QoL for post-surgical NSCLC 
patients starting within days 
after hospital discharge 
1. CRF; Brief Fatigue Inventory (BFI) 
2. Secondary outcome measures are listed below; 
• Symptom severity and interference was assessed using M.D. 
Anderson Symptom Inventory Core and Lung Module 
(MDASI) 
• Functional status; Medical Outcomes SF-36 
• QoL; Ferrans and Powers Quality of Life Index (QLI) (assessing 
satisfaction and important aspects of life to the person)  
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Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
 
Schmidt et al, 
2014                        
(Germany) 
Breast,  
Adjuvant chemo 
Resistance 
exercise training 
To investigate whether 
progressive resistance training 
in breast cancer patients during 
chemotherapy provides 
beneficial effects on fatigue and 
QoL beyond the potential 
effects of a supervised group-
based training 
 
1. Fatigue; Fatigue Assessment Questionnaire (FAQ) 
2. Secondary outcome measures are listed below; 
• QoL; EORTC QLQ-C30 
• Depression; 20-item Center for Epidemiological Studies 
Depression scale) 
• Cognitive function (concentration, cognitive flexibility); trail-
making-test 
Naraphong et al, 
2014       
(Thailand) 
Breast, 
Adjuvant chemo 
Walking 
programme 
To preliminarily examine the 
effects of an exercise 
programme on the symptoms 
of fatigue, sleep disturbance, 
mood disturbance, symptom 
distress and physical fitness for 
Thai women 
 
1. Fatigue; Revised Piper Fatigue Scale (PFS) 
2. Secondary outcome measures are listed below; 
• Sleep disturbance; General Sleep Disturbance)  
• Mood disturbance; Profile of Mood States-Brief Form 
• Distress; Memorial Symptom Assessment Scale (MSAS) 
 
Husebo et al, 
2014        
(Norway) 
Breast cancer, 
Adjuvant chemo 
 
Walking 
programme and 
strength 
exercise 
Investigate the effects of a 
scheduled home-based exercise 
intervention on CRF, physical 
fitness and activity level. 
1. CRF; Schwartz Cancer Fatigue Scale-6 
2. Secondary outcome measures are listed below; 
• Physical activity;  International Physical Activity 
Questionnaire 
• Physical fitness ; 6-MWT 
• Exercise volume; exercise diaries 
• Exercise adherence; extent to which the women in the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Author, 
year, (Country) 
Cancer type, 
Cancer treatment 
Exercise 
Programme 
Study aim 1. Primary outcome measure 
2. Secondary outcome measure 
intervention group performed the prescribed exercise 
regimen 
Abbreviations: Chemo – chemotherapy, HRQoL – health related quality of life, QoL – quality of life, 1-RM – repetition maximum, SF-36; The Short Form (36) Health 
Survery, VO2Peak – oxygen uptake at peak exercise, VO2max – oxygen uptake at max exercise, CPET – Cardiopulmonary exercise test, 12 MWD- 12 minute walk distance 
test, 6MWD – 6 minute walk distance test, CRF – cancer related fatigue 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Summary of study characteristics and exercise intervention outcomes 
Author, Study N Gender Cancer type, Exercise Supervision, Frequency Intensity Duration Adherence Primary 
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year, 
(Country) 
 
design Cancer 
treatment 
Programme Location outcome 
Segal et al, 
2001 
(Canada) 
RCT 
 
 
123 Female Breast, 
Adjuvant 
chemo/ 
other 
adjuvant 
cancer 
treatment 
Walking 
programme 
Supervised & 
home based 
Home; 
5times/week 
 x 26 weeks. 
In-hospital; 
3times x 
26weeks 
50-60% 
VO2Peak 
NR 71.5%  *Physical 
functioning  
(in UC) 
 
Kolden et 
al, 2002 
(USA) 
Pilot 
study 
40 
 
Female Breast, 
Adjuvant 
radiotherapy 
Aerobic/ 
resistance 
training 
Supervised 3times/week 
x 16 weeks 
Prog: 
40-70% 
VO2Max 
 
60min 78.4% *Fitness & 
Qol 
flexibility 
 
Campbell 
et al, 2005 
(UK) 
Pilot 
RCT 
22 Female Breast, 
Adjuvant 
radiotherapy 
& chemo 
Aerobic 
training 
Supervised 2times/week  
x 12 weeks 
60-75% MHR 
 
NR 70% * Qol 
measure (in 
EG) 
Mock et al, 
2005 
(USA) 
RCT 119 Female Breast 
Adjuvant 
radiotherapy 
 
Walking 
programme 
 
Home-based 
Unsupervised 
5-6times 
/week  
x 6-weeks 
during RET 
or 
3-6months 
50-70% MHR 
 
15-30 
min 
EG: 72% 
UG: 61%  
Fatigue & 
physical 
functioning 
 
Battaglini 
et al, 2006 
(USA) 
RCT 20 Female Breast 
Adjuvant 
Chemo, 
radiation or 
both 
CV/ 
resistance/ 
flexibility 
training 
 
Supervised 
 
 
 
2times/week 
 x 16 weeks 
40-60% max 
exercise 
capacity 
60min NR 
 
 
 
*Muscular 
strength, 
fatigue 
 
Courneya 
et al, 2007 
(Canada) 
RCT 242 Female Breast, 
Adjuvant 
chemo 
Aerobic/ 
resistance 
training 
Supervised 
In-hospital 
Duration of 
chemo 
Prog: 
60-80% 
VO2Peak/1RM 
15-45min 70.2% ↑ QoL 
measure, 
*↑ chemo 
completion 
rate in RET 
Lee et al, 
2007 
Single- 
blind 
61 
 
Female Breast, 
Adjuvant 
Pectoral 
muscle 
Unsupervised 
Home based 
2times/day  
X 7days  
NR 10min 90% Range of 
motion  
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(Australia) RCT 
 
radiotherapy stretching 
programme 
x 6 weeks 
 
Courneya 
et al, 2008 
(Canada) 
RCT 242 Female Breast, 
Adjuvant 
chemo 
Aerobic/ 
resistance 
training 
Supervised 
In-hospital 
3 
times/week 
x 17 weeks 
60-80% 
VO2Peak/ 60-
70% 1RM 
15- 45 min A; 72% 
R; 68.2% 
Measure of 
QoL 
 
Jones et al, 
2008 
(Canada) 
Pros. 
single 
group 
20 
 
Mixed 
gender 
Lung, 
Adjuvant 
chemo & 
some 
received no 
chemo 
Aerobic 
training 
 
Supervised: 
short term 
3 
times/week 
x14 weeks 
Prog: 
60-70% 
WRpeak 
15-45 min ©93% and 
72%, 
NC;85% 
Feasible, 
*↑Qol and 
select CP (in 
NC only) 
 
Adamsen 
et al, 2009  
(Denmark) 
RCT 
 
269 Mixed 
gender 
21 different 
cancers, 
59 different 
chemo 
regimens 
Resistance 
training, 
relaxation, 
body 
awareness 
and 
massage 
Supervised 
In-hospital 
9hours/week 
x 6weeks 
 
 
Low & high 
intensity 
90min 70.8% *Fatigue, 
Variety of 
QoL 
measures,  
Other QoL 
measures  
Courneya 
et al 2009 
(Canada) 
Pros. 
RCT 
242 Female Breast, 
Adjuvant 
chemo 
Aerobic/ 
Resistance 
training 
Supervised 
In-hospital 
3 
times/week 
x 17weeks 
60-80% 
VO2Peak/ 60-
70% IRM 
60min A;72% 
R;68.2% 
Measure of 
exercise 
patterns 
 
Moros et 
al, 2010 
(Spain) 
RCT 22 Female Breast, 
Adjuvant 
chemo 
Aerobic/  
muscle 
strength/ 
coordination 
training 
 
Supervised 
In-hospital 
3 times week 
x 18-22-
weeks 
 
60-70% HR 60min 91% Functional 
capacity, 
*QoL 
Milecki et 
al, 2013 
(Poland) 
RCT 46 Female Breast, 
Adjuvant 
radiotherapy 
Aerobic/ 
endurance, 
respiratory 
muscle 
training 
Supervised, 
In-Hospital 
5times / 
week x 6 
weeks 
65-70% MHR 40-45 
min 
NR 6MWD 
Hoffman Pilot 7 Mixed NSCLC, Walking and Home based 5times/week Prog:  Light NR CRF, other 
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et al, 2014 
(USA) 
gender Chemo 
(initiated 
week 5 in 
5/7 patients) 
 
balancing 
program 
(Nintendo 
Wii Fit Plus) 
X 6weeks 5-30min intensity symptoms, 
functional 
status, QoL 
Schmidt et 
al, 
2014  
(Germany) 
Prop. 
RCT 
101 Female Breast,  
Adjuvant 
chemo 
Resistance 
exercise 
training 
Supervised, 
Training 
facility 
2/week x 12 
weeks 
60-80% IRM 60  min 71% Fatigue, 
QoL, 
depression, 
cognitive 
function, 
effect 
modification 
Naraphong 
et al, 2014 
(Thailand) 
Pilot 23 Female Breast, 
Adjuvant 
chemo 
Walking 
programme 
Home based 3-5 
days/week x 
12 weeks 
Prog; 20-
30min 
Prog; light 
to 
moderate 
Reported 
as increase 
in mean 
5920 steps 
Feasibility, 
CRF, 
physical 
fitness, 
mood and 
sleep 
disturbance 
Husebo et 
al, 2014 
(Norway) 
RCT 67 Female Breast 
cancer, 
Adjuvant 
chemo 
 
Strength/ 
aerobic 
training 
 
Home based Daily x 
17weeks 
Self-reported 30 min Walking-
17% 
Strength-
15% 
CRF, 
physical 
fitness, 
physical 
activity 
 
Abbreviations: RCT – randomised controlled trial, Prop – prospective study, NR – not report, Chemo – chemotherapy * - significant findings, RCT- randomised controlled 
trial, chemo-chemotherapy, VO2Peak – oxygen uptake at peak exercise, VO2max – oxygen uptake at max exercise, VO2 at LT- oxygen uptake at lactate threshold, 1RM – 1 
rep maximum, UC- Usual care, Prog-progressive, IG/EG; Intervention group, CG; Control group, MHR- max heart rate, Min- minute, Prog – progressive increase, RET – 
resistance training, QoL; quality of life, CP –Cardiopulmoanry endpoints, Note# - UC offered 1month supervised exercise post intervention, AET- Aerobic exercise training, 
RET- resistance exercise training, Pros –prospective, WRpeak – peak work rate, 6MWD-6 minute walk distance test, CRF – cancer related fatigue. * - significant findings, 
RCT- randomised controlled trial, V& o2 at θˆ L- oxygen uptake at lactate threshold, Prog-progressive, Min- minute. 
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APPENDIX 1. Literature review search terms 
 
 
 
Search terms 
i) CANCER 
1. expNeoplasm 
2. Canc*.tw. 
3. Neoplasm*.tw. 
4. expTumor 
5. Tumo*.tw. 
6. expCarcinoma 
7. Carcin*.tw. 
8. expMalignant 
9. expOncology 
10. Oncol*tw. 
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
ii)  CANCER TREATMENT 
12. expNeoadjuvant 
13. Neoadjuvant*.tw. 
14. expChemo 
15. Chemo*.tw. 
16. expRadiotherapy 
17. expCancer treatment 
18. 12 or 13 or 14 or 15 or 16 or 17 
iii) EXERCISE 
19. expExercise 
20. Exercise*.tw. 
21. expFitness 
22. Fit*.tw. 
23. expOxygen consumption 
24. expAerobic 
25. Aerobic*.tw. 
26. Anaerobic 
27. Anaerobic*.tw. 
28. 19 or 20 or 21 or 21 or 22 or 23 or 24 or 25 or 26 or 27 
i) and ii) and iii) 
iv) SURGERY 
29. Surgery 
30. Surg*.tw. 
31. Surgical (including Anatomy, drainage, mortality, patient, science, stress, wound, ward all 
terms) 
32. 30 or 31 or 32 
33. I) and ii) and iii) and iv) 
v) OUTCOME 
34. Morb*.tw. 
35. Mort*.tw. 
36. Recurrence*.tw. 
37. Outcom*.tw. 
38. 34 or 35 or 36 or 37 
i) and ii) and iii) and iv) and v)  
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APPENDIX 2. Quality assessment 
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Reporting                                   
Is the hypothesis/aim/objective of the study 
clearly described? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Are the main outcomes to be measured clearly 
described in the introduction or methods section? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Are the characteristics of the patients included in 
the study clearly described? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Are the interventions of interest clearly 
described? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Are the distributions of principal confounders in 
each group of subjects to be compared clearly 
described? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Are the main findings of the study clearly 
described? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Does the study provide estimates of the random 
variability in the data for the main outcomes? 
1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Have all important adverse events that may be a 
consequence of the intervention been reported? 
1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 0 1 
Have the characteristics of patients lost to 
follow-up been described 
0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 
Have actual probability values been reported for 
the main outcomes except where the probability 
value is less than 0.001? 
1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 
External validity                                   
Were the subjects asked to participate in the 
study representative of the entire population 
from which they were recruited? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
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Were those subjects who were prepared to 
participate representative of the entire population 
from which they were recruited? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Were the staff, places, and facilities where the 
patients were treated, representative of the 
treatment the majority of patients receive? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Internal validity bias                                   
Was an attempt made to blind study subjects to 
the intervention they have received? 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Was an attempt made to blind those measuring 
the main outcomes of the intervention? 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
If any of the results of the study were based on 
data dredging, was this made clear? 
1 1 1 1 1 1 1 1 1 1 1 1 1  1 1 1 
In trials and cohort studies, do the analyses 
adjust for different lengths of follow-up of 
patients, or in case-control studies, is the time 
period between the intervention and outcome the 
same for case controls? 
1 0 0 0 0 1 0 0 0 0 0 0 1 1 1 1 1 
Were the statistical tests used to assess the main 
outcomes appropriate? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 
Was compliance with the intervention/s reliable? 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Were the main outcome measures used accurate 
(valid and reliable)? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Internal validity - confounding (selection bias)                                   
Were the patients in different intervention 
groups (trials and cohort studies) or were the 
cases and controls (case-control studies) 
recruited from the same population? 
1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 
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Were study subjects in different intervention 
groups (trials and cohort studies) or were the 
cases and controls (case-control studies) 
recruited over the same period of time? 
1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 
Were the study subjects randomised to 
intervention groups? 
1 1 1 0 1 1 1 1 1 0 1 1 1 0 1 1 1 
Was the randomised intervention assignment 
concealed from both patients and health care 
staff until recruitment was complete and 
irrevocable? 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Was there adequate adjustment for confounding 
in the analyses from which the main findings 
were drawn? 
1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 
Were losses of patients to follow-up taken into 
account? 
1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 
Power                                   
Did the study have sufficient power to detect a 
clinically important effect where the probability 
value for a difference being due to chance is less 
than 5%? 
1 0 0 0 1 1 1 1 0 0 1 1 1  1 0 1 
Total 23 20 21 17 23 24 23 23 22 19 23 23 21 21 24 21 24 
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APPENDIX 3. Search results conducted for this systematic review        
 
 
Articles 
identified 6489
•Identified through database search;EMBASE (1179), MEDLINE (4892), Sportsdiscus (16), Web 
of Science (402), Cochrane (0) 
Excluded 6395
•Articles excluded due to; not including a form of cancer therapy, surgery and a form of 
exercise
Screened 96 
articles
•Articles excluded due to; not including both cancer therapy and surgery, exercise 
interventions initiated in cancer survivors and in abstract format
•Full text articles (n=17)
